Emlidus 25/5 mg is an oral tablet manufactured by Opsonin Pharma Ltd. in Bangladesh. It combines two active ingredients: Empagliflozin (25 mg) and Linagliptin (5 mg). This combination is used to improve glycemic control in adults with type 2 diabetes mellitus.